629 related articles for article (PubMed ID: 16949997)
1. Chapter 2: The burden of HPV-related cancers.
Parkin DM; Bray F
Vaccine; 2006 Aug; 24 Suppl 3():S3/11-25. PubMed ID: 16949997
[TBL] [Abstract][Full Text] [Related]
2. Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003.
Ekwueme DU; Chesson HW; Zhang KB; Balamurugan A
Cancer; 2008 Nov; 113(10 Suppl):2936-45. PubMed ID: 18980277
[TBL] [Abstract][Full Text] [Related]
3. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.
Watson M; Saraiya M; Ahmed F; Cardinez CJ; Reichman ME; Weir HK; Richards TB
Cancer; 2008 Nov; 113(10 Suppl):2841-54. PubMed ID: 18980203
[TBL] [Abstract][Full Text] [Related]
4. Burden and trends of type-specific human papillomavirus infections and related diseases in the latin america and Caribbean region.
Parkin DM; Almonte M; Bruni L; Clifford G; Curado MP; Piñeros M
Vaccine; 2008 Aug; 26 Suppl 11():L1-15. PubMed ID: 18945399
[TBL] [Abstract][Full Text] [Related]
5. Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region.
Parkin DM; Louie KS; Clifford G
Vaccine; 2008 Aug; 26 Suppl 12():M1-16. PubMed ID: 18945410
[TBL] [Abstract][Full Text] [Related]
6. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
Syrjänen KJ
Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
[TBL] [Abstract][Full Text] [Related]
7. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003.
Ryerson AB; Peters ES; Coughlin SS; Chen VW; Gillison ML; Reichman ME; Wu X; Chaturvedi AK; Kawaoka K
Cancer; 2008 Nov; 113(10 Suppl):2901-9. PubMed ID: 18980273
[TBL] [Abstract][Full Text] [Related]
8. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases.
Clifford G; Franceschi S; Diaz M; Muñoz N; Villa LL
Vaccine; 2006 Aug; 24 Suppl 3():S3/26-34. PubMed ID: 16950015
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus: often harmless but in some cases carcinogenic.
Prescrire Int; 2007 Jun; 16(89):115-9. PubMed ID: 17585425
[TBL] [Abstract][Full Text] [Related]
10. Examining the association between socioeconomic status and potential human papillomavirus-associated cancers.
Benard VB; Johnson CJ; Thompson TD; Roland KB; Lai SM; Cokkinides V; Tangka F; Hawkins NA; Lawson H; Weir HK
Cancer; 2008 Nov; 113(10 Suppl):2910-8. PubMed ID: 18980274
[TBL] [Abstract][Full Text] [Related]
11. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection.
Burchell AN; Winer RL; de Sanjosé S; Franco EL
Vaccine; 2006 Aug; 24 Suppl 3():S3/52-61. PubMed ID: 16950018
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology behind the HPV vaccine discovery.
Koutsky L
Ann Epidemiol; 2009 Apr; 19(4):239-44. PubMed ID: 19344861
[TBL] [Abstract][Full Text] [Related]
13. How much cervical cancer in Australia is vaccine preventable? A meta-analysis.
Brotherton JM
Vaccine; 2008 Jan; 26(2):250-6. PubMed ID: 18068276
[TBL] [Abstract][Full Text] [Related]
14. [Involvement of human papillomavirus in upper aero-digestive tracts cancers].
Neufcoeur PE; Arafa M; Delvenne P; Saussez S
Bull Cancer; 2009 Oct; 96(10):941-50. PubMed ID: 19744917
[TBL] [Abstract][Full Text] [Related]
15. Burden and incidence of human papillomavirus-associated cancers and precancerous lesions in Denmark.
Svahn MF; Munk C; von Buchwald C; Frederiksen K; Kjaer SK
Scand J Public Health; 2016 Aug; 44(6):551-9. PubMed ID: 27289104
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
17. New evidence for geographic variation in the role of human papillomavirus in tonsillar carcinogenesis.
Li W; Tran N; Lee SC; O'Brien CJ; Tse GM; Scolyer RA; Hong A; Milross C; Yu KH; Rose BR
Pathology; 2007 Apr; 39(2):217-22. PubMed ID: 17454751
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of papillomavirus-associated cancer].
Signorelli C
Ann Ig; 2008; 20(3 Suppl 1):65-74. PubMed ID: 18773608
[TBL] [Abstract][Full Text] [Related]
19. Cancer attributable to human papillomavirus infection in China: Burden and trends.
Lu Y; Li P; Luo G; Liu D; Zou H
Cancer; 2020 Aug; 126(16):3719-3732. PubMed ID: 32484937
[TBL] [Abstract][Full Text] [Related]
20. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
Schneider A; Schwarz TF; Hammerschmidt T; Siebert U
Med Klin (Munich); 2007 Jul; 102(7):515-23. PubMed ID: 17634869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
